Cardio Diagnostics Plans Investor Call on Disease Data, FDA Strategy and India Launch
Cardio Diagnostics said it will host an investor call on December 10 to discuss non-obstructive coronary artery disease data, its FDA Breakthrough Device designation strategy and an India launch update.